RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5
- PMID: 31108998
- PMCID: PMC6562819
- DOI: 10.3390/cancers11050691
RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5
Abstract
The small GTPase Ras-related C3 botulinum toxin substrate 1B (RAC1B) has been shown previously by RNA interference-mediated knockdown (KD) to function as a powerful inhibitor of transforming growth factor (TGF)-β1-induced cell migration and epithelial-mesenchymal transition in epithelial cells, but the underlying mechanism has remained enigmatic. Using pancreatic carcinoma cells, we show that both KD and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9-mediated knockout (KO) of RAC1B increased the expression of the TGF-β type I receptor ALK5 (activin receptor-like kinase 5), but this effect was more pronounced in CRISPR-KO cells. Of note, in KO, but not KD cells, ALK5 upregulation was associated with resensitization of TGFBR1 to induction by TGF-β1 stimulation. RAC1B KO also increased TGF-β1-induced C-terminal SMAD3 phosphorylation, SMAD3 transcriptional activity, growth inhibition, and cell migration. The KD of ALK5 expression by RNA interference or inactivation of the ALK5 kinase activity by dominant-negative interference or ATP-competitive inhibition rescued the cells from the RAC1B KD/KO-mediated increase in TGF-β1-induced cell migration, whereas the ectopic expression of kinase-active ALK5 mimicked this RAC1B KD/KO effect. We conclude that RAC1B downregulates the abundance of ALK5 and SMAD3 signaling, thereby attenuating TGF-β/SMAD3-driven cellular responses, such as growth inhibition and cell motility.
Keywords: ALK5; CRISPR/Cas9; RAC1B; RNA interference; TGF-β; cell migration; pancreatic carcinoma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
RAC1B Induces SMAD7 via USP26 to Suppress TGFβ1-Dependent Cell Migration in Mesenchymal-Subtype Carcinoma Cells.Cancers (Basel). 2020 Jun 11;12(6):1545. doi: 10.3390/cancers12061545. Cancers (Basel). 2020. PMID: 32545415 Free PMC article.
-
RAC1B Suppresses TGF-β-Dependent Chemokinesis and Growth Inhibition through an Autoregulatory Feed-Forward Loop Involving PAR2 and ALK5.Cancers (Basel). 2019 Aug 20;11(8):1211. doi: 10.3390/cancers11081211. Cancers (Basel). 2019. PMID: 31434318 Free PMC article.
-
RAC1B: A Guardian of the Epithelial Phenotype and Protector Against Epithelial-Mesenchymal Transition.Cells. 2019 Dec 4;8(12):1569. doi: 10.3390/cells8121569. Cells. 2019. PMID: 31817229 Free PMC article.
-
The role of small GTPases of the Rho/Rac family in TGF-β-induced EMT and cell motility in cancer.Dev Dyn. 2018 Mar;247(3):451-461. doi: 10.1002/dvdy.24505. Epub 2017 May 30. Dev Dyn. 2018. PMID: 28390160 Review.
-
The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma.Cell Commun Signal. 2017 May 12;15(1):19. doi: 10.1186/s12964-017-0175-0. Cell Commun Signal. 2017. PMID: 28499439 Free PMC article. Review.
Cited by
-
Clusterin negatively modulates mechanical stress-mediated ligamentum flavum hypertrophy through TGF-β1 signaling.Exp Mol Med. 2022 Sep;54(9):1549-1562. doi: 10.1038/s12276-022-00849-2. Epub 2022 Sep 21. Exp Mol Med. 2022. PMID: 36131026 Free PMC article.
-
Autocrine TGFβ1 Opposes Exogenous TGFβ1-Induced Cell Migration and Growth Arrest through Sustainment of a Feed-Forward Loop Involving MEK-ERK Signaling.Cancers (Basel). 2021 Mar 17;13(6):1357. doi: 10.3390/cancers13061357. Cancers (Basel). 2021. PMID: 33802809 Free PMC article.
-
RAC1B Induces SMAD7 via USP26 to Suppress TGFβ1-Dependent Cell Migration in Mesenchymal-Subtype Carcinoma Cells.Cancers (Basel). 2020 Jun 11;12(6):1545. doi: 10.3390/cancers12061545. Cancers (Basel). 2020. PMID: 32545415 Free PMC article.
-
Negative Control of Cell Migration by Rac1b in Highly Metastatic Pancreatic Cancer Cells Is Mediated by Sequential Induction of Nonactivated Smad3 and Biglycan.Cancers (Basel). 2019 Dec 6;11(12):1959. doi: 10.3390/cancers11121959. Cancers (Basel). 2019. PMID: 31817656 Free PMC article.
-
The Quasimesenchymal Pancreatic Ductal Epithelial Cell Line PANC-1-A Useful Model to Study Clonal Heterogeneity and EMT Subtype Shifting.Cancers (Basel). 2022 Apr 19;14(9):2057. doi: 10.3390/cancers14092057. Cancers (Basel). 2022. PMID: 35565186 Free PMC article.
References
-
- Ungefroren H., Sebens S., Giehl K., Helm O., Groth S., Fandrich F., Rocken C., Sipos B., Lehnert H., Gieseler F. Rac1b negatively regulates TGF-beta1-induced cell motility in pancreatic ductal epithelial cells by suppressing Smad signalling. Oncotarget. 2014;5:277–290. doi: 10.18632/oncotarget.1696. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous